Invicta diagnostic limited IPO Overview
Invicta diagnostic limited IPO is a SME public issue offered through a Book Building issue with a total issue size of ₹28.12 Cr. The IPO price band is set at ₹80 to ₹85 per share, and retail investors can apply with a minimum investment of ₹2.72 L as per IPO guidelines.
The Invicta diagnostic limited IPO opens on 1 Dec 2025 and closes on 3 Dec 2025. The IPO allotment is expected to be finalized on 4 Dec 2025, and the equity shares are proposed to be listed on NSE on 8 Dec 2025.
Investors can refer to the Invicta diagnostic limited IPO RHP-DRHP for detailed information. The issue is managed by Socradamus Capital Pvt.Ltd. as the book running lead manager, while Bigshare Services Pvt Ltd is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About invicta diagnostic limited
Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (PET CT, MRI)
Three additional hubs (Bhayandar, Byculla, Marol) providing specialised diagnostic services
Three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging (X-ray, ultrasound) and sample collection.
The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.
Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels
Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.
As of October 31, 2025, the company employed 157 permanent employees.
Competitive Strength:
Expanding presence in the Mumbai Metropolitan Region (“MMR”), specifically in the radiology sector;
A diagnostics provider that offers a one-stop solution at an affordable price.
Technical capability and technology with IT infrastructure;
Dedicated management team with significant industry experience; and
Implementation of the Hub and Spoke Model.
Investment Objective
General Corporate purposes